title: Genetic analysis of the ELOVL6 gene polymorphism associated with type 2 diabetes mellitus.
abstract: Recent animal studies have indicated that overexpression of the elongation of long-chain fatty acids family member 6 (Elovl6) gene can cause insulin resistance and β-cell dysfunction. These are the major factors involved in the development of type 2 diabetes mellitus (T2DM). To identify the relationship between single nucleotide polymorphisms (SNP) of ELOVL6 and T2DM pathogenesis, we conducted a case-control study of 610 Han Chinese individuals (328 newly diagnosed T2DM and 282 healthy subjects). Insulin resistance and islet first-phase secretion function were evaluated by assessment of insulin resistance in a homeostasis model (HOMA-IR) and an arginine stimulation test. Three SNPs of the ELOVL6 gene were genotyped with polymerase chain reaction-restriction fragment length polymorphism, with DNA sequencing used to confirm the results. Only genotypes TT and CT of the ELOVL6 SNP rs12504538 were detected in the samples. Genotype CC was not observed. The T2DM group had a higher frequency of the C allele and the CT genotype than the control group. Subjects with the CT genotype had higher HOMA-IR values than those with the TT genotype. In addition, no statistical significance was observed between the genotype and allele frequencies of the control and T2DM groups for SNPs rs17041272 and rs6824447. The study indicated that the ELOVL6 gene polymorphism rs12504538 is associated with an increased risk of T2DM, because it causes an increase in insulin resistance.
authors.affiliation: Qingdao University, Department of Endocrinology, The Affiliated Hospital of Medical College, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: F
authors.initials: F
authors.lastname: Wang
authors.forename: X L
authors.initials: XL
authors.lastname: Yu
authors.forename: Z M
authors.initials: ZM
authors.lastname: Miao
authors.forename: Z C
authors.initials: ZC
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.forename: Y G
authors.initials: YG
authors.lastname: Wang
mesh_terms: D000123:Acetyltransferases / Q000235:genetics*; D000328:Adult; D002681:China / Q000208:ethnology; D003924:Diabetes Mellitus, Type 2 / Q000208:ethnology / Q000235:genetics*; D000081031:Fatty Acid Elongases; D005260:Female; D005838:Genotype; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics; D050417:Insulin-Secreting Cells / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012150:Polymorphism, Restriction Fragment Length; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*
chemical_list: C000630955:ELOVL6 protein, human; D000123:Acetyltransferases; D000081031:Fatty Acid Elongases
references.citation: J Mol Med (Berl). 2009 Apr;87(4):379-84
references.pmid: 19259639
references.citation: Nat Med. 2007 Oct;13(10):1193-202
references.pmid: 17906635
references.citation: Am J Med. 2012 Jul;125(7):679-687.e1
references.pmid: 22626509
references.citation: J Lipid Res. 2002 Jun;43(6):911-20
references.pmid: 12032166
references.citation: Curr Opin Rheumatol. 2013 Mar;25(2):210-6
references.pmid: 23370374
references.citation: Am J Physiol Endocrinol Metab. 2011 Apr;300(4):E640-9
references.pmid: 21266672
references.citation: Am J Hum Genet. 2009 Dec;85(6):775-85
references.pmid: 19944401
references.citation: Diabetes Care. 1998 Dec;21(12):2191-2
references.pmid: 9839117
references.citation: Diabetes. 2004 Dec;53 Suppl 3:S34-8
references.pmid: 15561919
references.citation: J Biol Chem. 2001 Nov 30;276(48):45358-66
references.pmid: 11567032
references.citation: Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
references.pmid: 20042772
references.citation: PLoS One. 2011;6(6):e21198
references.pmid: 21701577
references.citation: Am J Epidemiol. 2012 Jul 15;176(2):108-16
references.pmid: 22753829
references.citation: Eur J Pharmacol. 2010 Mar 25;630(1-3):34-41
references.pmid: 20045404